Dr. Rashmi Kumar, MD

Dr. Kumar practices at Hoag Endoscopy Center - Irvine in Irvine, California.

Dr. Kumar's NPI, 1396007068, was assigned on June 8, 2012. Dr. Kumar graduated from Patna Medical College in 2007. Dr. Kumar's California license number on file is A137822.

Dr. Kumar's primary practice is Hoag Endoscopy Center - Irvine, at 16405 Sand Canyon Ave, Suite 110, Irvine, CA 92618. The practice phone is (949) 764-4448.

Dr. Kumar's primary practice is Hoag Endoscopy Center - Irvine in Irvine, California. Dr. Kumar is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Kumar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kumar is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Kumar's licenses on file in 2 states: California and Arizona.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis and upper GI endoscopy among the conditions Dr. Kumar treats.

CMS data shows 235 Medicare services from Dr. Kumar across 9 procedure codes in 2024, for 109 Medicare patients. Medicare paid $22,668 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 109 Medicare patients who saw Dr. Kumar in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 52, with 65% women.

In 2024, Dr. Kumar wrote 173 Medicare Part D claims for 61 patients. 73% of them were for generic drugs. CMS names the drug for 83 of them, across 4 drugs with 11 or more claims each, at $17,933 in total drug cost. In 2023, CMS named 72 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kumar for performance year 2024, reported as part of a group. Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth. CMS counts 51 procedures of colonoscopy by Dr. Kumar, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Kumar, published from 2016 to 2025. 2025 was the busiest year, with 6. The most frequent topics are Kenya, Caregivers and Educational Status. Dr. Kumar has published most often in ACG Case Rep J. Dr. Kumar's most frequent co-authors are Michael Alon Angelo, MD, Niaz Banaei and Michele L. Donato, MD.

CMS Open Payments shows 349 general payments to Dr. Kumar from 29 drug and device companies from 2016 to 2025. Grants make up the largest share, 50% of the total. Pfizer Inc. paid the most, $84,078.

Dr. Kumar graduated from Patna Medical College in 2007.

Dr. Kumar is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.